## CAH: Cardinal Health, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -5.6% below STRENGTH zone (3.0-6.0%); PEG 1.63 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($190.13)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Cardinal Health, Inc. $CAH Shares Purchased by Quantbot Technologies LP**
- Source: MarketBeat | 20251204T010932 | Bullish | Relevance: 99%
-  Quantbot Technologies LP increased its stake in Cardinal Health, Inc. by 21.4% in Q2, making CAH its 19th-largest position. Analysts have a "Moderate Buy" rating with a consensus price target of $206.57, following strong Q2 results and increased FY2026 EPS guidance. The company also announced a quarterly dividend of $0.5107.

**2. Invesco Ltd. Acquires 207,750 Shares of Cardinal Health, Inc. $CAH**
- Source: MarketBeat | 20251205T122341 | Somewhat-Bullish | Relevance: 99%
- Invesco Ltd. increased its holdings in Cardinal Health, Inc. by 7.3% during the second quarter, acquiring an additional 207,750 shares and bringing its total ownership to 3,037,782 shares valued at $510,347,000. Other institutional investors also adjusted their stakes in Cardinal Health, which recently announced a quarterly dividend and surpassed analyst earnings estimates. Analysts currently rate Cardinal Health with a "Moderate Buy" consensus and an average price target of $206.57.

**3. Key facts: Cardinal Health prioritizes high ROI; officers surrender shares**
- Source: TradingView | 20251203T210623 | Somewhat-Bullish | Relevance: 99%
- Cardinal Health (CAH) focuses its capital deployment strategy on high return on investment opportunities, emphasizing shareholder returns and strategic mergers and acquisitions. Recently, on December 2, 2025, company officers surrendered 1,949 shares to cover costs associated with exercising options and tax liabilities, as reported to the SEC.

**4. 3 No-Brainer Dividend Stocks to Buy Right Now**
- Source: Finviz | 20251205T063900 | Bullish | Relevance: 99%
- This article identifies three dividend stocks — Cardinal Health (CAH), Chevron (CVX), and Target (TGT) — that offer compelling long-term prospects for dividend investors. It highlights Cardinal Health's successful transformation and potential for aggressive dividend growth, Chevron's renewed focus on shareholder value, and Target's sustainable high yield and potential for future substantial dividend increases amid a turnaround. The author emphasizes considering dividend growth track record and safety, not just yield, when evaluating dividend investments.

**5. Marshall Wace LLP Buys 309,335 Shares of Cardinal Health, Inc. $CAH**
- Source: MarketBeat | 20251205T125641 | Bullish | Relevance: 98%
-  Marshall Wace LLP increased its stake in Cardinal Health, Inc. (NYSE:CAH) by 19.1% in the second quarter, now owning 1,930,967 shares valued at $324,402,000. Several other institutional investors also adjusted their positions in CAH, with many increasing their holdings. Cardinal Health recently reported strong earnings, beating analyst estimates, and declared a quarterly dividend of $0.5107 per share.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $243 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 5 ($0.41M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Blackrock Inc.: 13.2% (+3.0%)
- Vanguard Group Inc: 13.0% (+0.8%)
- State Street Corpora: 5.2% (-3.0%)
- Geode Capital Manage: 2.7% (+1.5%)
- Wellington Managemen: 2.4% (+153.2%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-2.7% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.63 elevated, pricing in significant growth expectations. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $47.0B |
| Beta | 0.64 |
| 52W Range | $114.60 - $214.93 |
| Short Interest | 3.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.63 |
| Forward P/E | 17.9 |
| Current P/E | 20.2 |
| YoY Growth | 12.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -2.9% to -5.6% (-2.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.6pp (needs >3.0% for momentum thesis). Underperforming sector by 3.3pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.27x) but short-term weakness (below SMA20). MACD histogram bearish (-3.02), momentum weakening. RSI neutral at 52.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -5.57% (CS: 5) | Weak |
| RSI_14 | 51.6 | Neutral |
| MACD Histogram | -3.02 | Bearish |
| vs SMA20 | 0.963x | Below |
| vs SMA50 | 1.096x | Above |
| vs SMA200 | 1.275x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $198.83
- **Stop Loss:** $190.13 (4.4% risk)
- **Target:** $207.53 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 57
- **Position Value:** $11,333.31
- **Portfolio %:** 11.33%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite persisting. Mixed earnings signals with industrial weakness (John Deere) offset by consumer/tech strength, while institutional flows show selective positioning rather than broad risk-off. Fed meeting in 9 days provides near-term catalyst but current data suggests status quo maintenance.*

### Earnings

**Next:** 2026-01-29 (Est: $2.30)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.17 | $2.55 | +17.3% |
| 2025Q2 | $2.03 | $2.08 | +2.4% |
| 2025Q1 | $2.15 | $2.35 | +9.4% |
| 2024Q4 | $1.76 | $1.93 | +9.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*